Pregnancy Complications, Infectious
Pregnancy Complications, Infectious
Explore linked clinical trials. Standard reference: MESH:M00174777 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Systematic Screening of Lower Genital Tract Infections | Female Urogenital Diseases and Pregnancy Complications, Infections, Obstetric Labor Complications, Obstetric Labor, Premature, Pregnancy Complications, Infectious, Premature Birth, Premature Rupture of Fetal Membranes, Urogenital Diseases, pregnancy disorder | Not yet recruiting | Not applicable | 2026-06-17 | NCT07592286 | |
| The Impact of COVID-19 on Maternal and Neonatal Outcomes | COVID-19, Coronaviridae Infections, Female Urogenital Diseases and Pregnancy Complications, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pregnancy Complications, Infectious, RNA Virus Infections, Urogenital Diseases, lung disorder, pneumonia, pregnancy disorder, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-05-11 | NCT05197621 | |
| Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Disease Attributes, Female Urogenital Diseases and Pregnancy Complications, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pregnancy Complications, Infectious, RNA Virus Infections, Urogenital Diseases, chronic hepatitis C virus infection, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, pregnancy disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2026-04-15 | NCT05140941 | |
| EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 3) | Female Urogenital Diseases and Pregnancy Complications, Infections, Maternal Sepsis, Pregnancy Complications, Infectious, Urogenital Diseases, pregnancy disorder | Enrolling by invitation | Not stated | 2026-01-21 | NCT06160349 | |
| EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 2) | Female Urogenital Diseases and Pregnancy Complications, Infections, Maternal Sepsis, Pregnancy Complications, Infectious, Urogenital Diseases, pregnancy disorder | Enrolling by invitation | Not stated | 2026-01-21 | NCT06148532 | |
| EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1) | Female Urogenital Diseases and Pregnancy Complications, Infections, Maternal Sepsis, Pregnancy Complications, Infectious, Urogenital Diseases, pregnancy disorder | Recruiting | Not applicable | 2026-01-21 | NCT06145724 | |
| Azithromycin and Ampicillin for Late PPROM | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infections, Neonatal Diseases and Abnormalities, Obstetric Labor Complications, Obstetric Labor, Premature, Pregnancy Complications, Infectious, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Phase 4 | 2025-12-18 | NCT07183462 |